In particular, ELF3 was also reported to be a potential biomarker for detecting circulating tumor cells in NSCLC [12] and has been suggested to be a prognostic biomarker in lung adenocarcinoma (LUAD) [13]. This evidence concerns the gene ELF3 and non-small cell lung carcinoma.